World Collagen Conference

06th – 07th September, 2017
London, United Kingdom


“Outlook on the Global Collagen Market”

Global collagen market is anticipated to reach US$ 9,372.3 Mn by 2023, expanding at a CAGR of 9.4% during the forecast period from 2015 to 2023.

Asia-Pacific is forecast to emerge as the fastest growing market with a CAGR of 9.1% by 2020.


About the Event

Increasing consumer consciousness towards health and personal care coupled with rising trend for nutraceutical products are expected to fuel the growth of Collagen. Improving standard of living and growing fitness consciousness are likely to be the key drivers to propel demand. Global collagen market size was valued at more than USD 3 billion in 2015 and is likely to exceed USD 5 billion by 2023, growing at a CAGR of more than 7% from 2016 to 2023.

Gelatin market size, which is a collagen byproduct, dominated overall revenue and accounted for more than 60% of the total collagen market share in 2015, it was valued at more than USD 2.5 billion and is expected to exceed USD 2.8 billion by 2023. Collagen peptides market size was valued at more than USD 0.75 billion in 2015 and is likely to be worth around USD 1.25 billion by the end the forecast period.

Marine collagen market size was valued at more than USD 200 million in 2015; minimal disease transmission risk and relaxed regional and social regulations are expected to be the key factors driving growth. In terms of application, cosmetics were the major contributor, with total volume of over 4.2 kg tonnes in 2015 owing to benefits such as anti aging properties and personal & hygiene products demand.

The gelatin market is dominated by Europe, and is likely to grow at a significant rate due to the growth in end-use industries such as food & beverages and pharmaceuticals. Asia-Pacific is anticipated grow at a high rate due to increase in per capita income and fast-paced industrialization.

Applications can be segmented into cosmetics, food & beverages, nutraceuticals, healthcare and pharmaceuticals. Food & beverages can be further bifurcated into beer, wine, cakes, jellies, ice-creams, refined sugar, and non-dairy creamer. Increase in consumption and growing food industry is likely to contribute to industry growth.

Nutraceuticals and pharmaceutical sector is anticipated to grow at a higher rate owing to the vast applications in these segments. Healthcare includes orthopedic, dental and surgery procedures, wherein collagen helps in constructing artificial skin in order to heal burns and wounds. Increasing geriatric population accompanied by increasing problems related to the skin and bones is expected to the boost demand. Increasing healthcare spending among consumers accompanied by FDA & IMA approvals for gelatin to be used in drugs and food preservatives has also fueled growth.

The collagen industry is characterized by increasing R&D activities for drug development, rising social awareness about personal health, and growing wound healing & regenerative medicines industry. Increasing food grades prices and huge importing cost is likely to restrain growth.

The World Collagen Conference will discuss the industry’s growth forecast, analyse the regulatory trends, drivers, industry pitfalls, challenges and growth opportunities for participants, the leading market products, applications & regions and how will they perform, the technology & innovation trends, how will they evolve, highlight how companies are they positioned in the market in terms of sustainability, competency, production capacity and strategic outlook.

  • An overview of global collagen market
  • The market size and the growth rate of collagen products by 2023
  • Visualisation of newly synthesised collagen in vitro and in vivo

  • Outlining Innovations and advancements in collagen production

  • Gene regulation and functional aspects of collagen biosynthesis
  • The diversity of collagens in development, disease and tissue repair


06-07 September, 2017
London, United Kingdom

Day 1: 06th September, 2017
Comprehending the Burgeoning Role of Collagen Supplements in Healthcare and Skincare Industry


Asma Ishaq
President, Collagen Sciences & Chief Industry Relations Officer

Area for Growth in Skin Care – Probing into Latest Collagen Formulations Enhancing Skin care


Steffen Oesser
Collagen Research Institute
10.30 AM Morning Coffee Break & Networking
Growing Role of Fish Collagen in the Field of Skincare and Healthcare





Dr Christelle BONNET
Innovation/Preclinical and Clinical Research manager

1.00 PM Networking Lunch
Probing into Benefits of Using Hydrolyzed Collagen as a Cosmetic Ingredient


Dr. Martin Godfrey
Head of Research and Development
Minerva Research Labs

3.20 PM Afternoon Coffee Break & Networking
5.00 PM End of Day 1
Day 2: 07th September, 2017
Oral Collagen Peptides for Healthy and Active Ageing: Evidence for Benefits from Skin beauty to Musculoskeletal Health


Dr Janne Prawitt
Global Nutrition Manager

Looking into Production of Hydrolysed Collagen from Fishery By-products


Margrét Geirsdóttir
Project Manager

10.30 AM Morning Coffee Break & Networking
New Research: Collagen Peptide Supplements Improving Skin Morphology of Cellulite-affected Areas



1.00 PM Networking Lunch
2.00 PM End of Conference

*Agenda content and timeline subject to change.


Asma Ishaq
President, Collagen Sciences
Chief Industry Relations Officer

Asma Ishaq has united experience and vision to establish innovative concepts in health and beauty industries. Asma founded an award-winning company with an award-winning product line based on multi-patented Liquid BioCell® nutraceutical ingredient that has pioneered the collagen and hyaluronic acid dietary supplement and skincare markets. Her company both maintained high standards in business ethics across distribution channels and industries while championing new product technology.

Her extensive background in product development, formulation, skincare and nutritional supplement manufacturing well-prepared her to be founder and president of Modere’s Collagen Sciences division, and serve as the company’s Chief Industry Relations Officer. Before starting her own company in 2009, she held executive positions at BioCell Technology and GMP Laboratories. Asma serves the direct-selling channel on the DSA Board of Directors, the nutrition industry as a Committee Member on the Council of Responsible Nutrition and is on the advisory panel of the International Fragrance Association of North America (IFRANA). Also a celebrated speaker, Asma has spoken at dozens of conferences, tv shows, and radio programs. She earned her B.A. from the University of California, Berkeley and received a dual M.B.A. in finance and marketing from Rice University.

Dr Christelle BONNET
Innovation/Preclinical and clinical Research manager,

Christelle BONNET followed her classes in the French education system with a Masters degree in Biology/ Nutrition from the Engineering school of Montpellier and a PhD in Biology and Biotechnology. After receiving her Masters degree, Christelle worked for over 5 years in the food industry as a R&D manager. As she wanted to learn more about how active compounds may show their bio-functionalities, she embarked on a PhD, researching the effects of polyphenols (dopamine, leucocyanidine, etc) and phystosterols (sitoindosides) from Musa cavendish on cardiovascular and anti-ulcerogenic activities. The French Research Ministry awarded Christelle an Innovation Prize for her work in this area.

Seven years ago, Christelle joined Weishardt in order to support scientific and technical development of Naticol®, fish collagen peptides.  She is now responsible for the coordination of clinical and preclinical scientific studies in order to develop and investigate a portfolio of fish collagen peptides (Naticol®) for food, nutraceutical, pharmaceutical industries in relation to their health benefits. Her main responsibilities include design and monitoring preclinical and clinical research, writing literature reports and scientific articles, public and private collaborations, financial support implementation (FEDER/ Région),intellectual property. More recently, Christelle contributed as an inventor in the conception of the main ideas in the patent claims of a patent therapeutic application.


Dr Martin Godfrey
Head, Research and Development
Minerva Research Labs

Dr Martin Godfrey has over 25 years experience working in the health sector. His key areas of expertise lie in the areas of nutriceutical and pharmaceutical research, and marketing communications. Martin works with a team of PhDs who in turn are focussed on developing robust, clinical and in vitro research in partnership with leading academic centres around the world. The team has so far published 5 original papers in peer review journals and have a healthy pipeline of studies in progress.


Dr Janne Prawitt
Principal Scientist–Nutrition

Dr Janne Prawitt is the Principal Scientist – Nutrition at Rousselot where she is responsible for the Nutrition and Health Science portfolio supporting Peptan®, Rousselot’s collagen peptides. A nutritional scientist by education she has spent 10 years in academic research in Germany and France, investigating mechanisms that contribute to the development of metabolic diseases such as obesity and diabetes. Janne joined Rousselot in 2013, where her main interest is to understand the benefit of collagen peptides for musculoskeletal health and skin physiology, and to develop related products for the global market.


Margrét Geirsdóttir
Project Manager

Margrét Geirsdóttir is a project manager at Matís – Icelandic Food and Biotech R&D. She has been working at Matis – previously Icelandic Fisheries Laboratories – from 1998 were her main research areas have been utilization of fish proteins from underutilized raw materials, extraction, functional properties, hydrolysation and bioactive properties. In the past two years her main focus has been on isolation and hydrolysation of collagen from fish skin.

Dr. Steffen Oesser
Collagen Research InstituteUniversity of Kiel

Dr. Steffen Oesser studied biology and chemistry at the University of Kiel in Germany. As a Scientific Assistant at the Institute for Physiology of the University of Kiel, he initially concentrated on the areas of cell physiology and protein chemistry. Since 1993, Dr. Oesser has been active in medical research at the Hospital for General and Thoratic Surgery at the Kiel campus of the University Hospital of Schleswig-Holstein, Germany. He is principally involved in researching the pathophysiology of connective tissue diseases and the development of new therapy possibilities for the treatment of degenerative processes in the extracellular matrix of connective tissue cells. Dr. Oesser has been the Director of the Collagen Research Institute (CRI) in Kiel, Germany since October 2003.

 All Conference Session
 Conference Proceedings  
 On-Site Lunches
 Refreshment Breaks
Table-Top Exhibiton Display  
Logo Promotion  
  Register Register 

Register 3 Send 4th One Free Any organization wishing to send multiple attendees to this conference may send 1 FREE for every 3 delegates registered. Please note that all the 3 participants must register at the same time to avail this benefit.

Note: All payments are made in Pounds.
Registration fee only covers cost of all sessions, luncheon, coffee/tea & presentations. Fee does NOT include any travel or accommodation expenses. Fee is not inclusive of 8% Admin/Bank Charges.


Novotel London City South Hotel
Address: 53-61 Southwark Bridge Rd, London SE1 9HH, UK
Phone: +44 20 7660 0676

Name (required)

Email (required)

Phone Number(with country code): (required)

Select Event (required)


Your Message


Our Clients